Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Inclacumab Biosimilar – Anti-SELP mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Inclacumab Biosimilar - Anti-SELP mAb - Research Grade |
|---|---|
| Source | CAS 1256258-86-2 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Inclacumab,LC1004-002,RO4905417,SELP,anti-SELP |
| Reference | PX-TA1279 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Inclacumab Biosimilar - Anti-SELP mAb - Research Grade
General information on Anti-SELP[Homo sapiens] (Inclacumab) Monoclonal Antibody
Inclacumab has investigated for the treatment and prevention of Myocardial Infarction, Peripheral Arterial Disease (PAD), and Coronary Heart Disease.
Related products
Antigen
Human CD62P-SELP recombinant protein
PX-P6095 420€
ELISA
Inclacumab ELISA Kit
KPTX192 1179€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.